Shukun (Beijing) Technology Co., Ltd.
- Industry
- Healthcare IT
- Founded Year
- 2017
- Headquarters
- Beijing, China
- Employee Count
- 47
Key People
- Chun'e Ma - Founder and CEO
- Vicki Wang - Co-CFO; Head of IR; Head of Overseas Business
- Ning Guo - Director, Clinical Research Center
- Xiao Wang - Director of Strategic Development
- Jing Yang - HR Director
Assessment
- Team
-
Aspect: First-time 10+ yrs
Summary: The leadership team comprises experienced professionals with over a decade in their respective fields.
The leadership team's background suggests a strong foundation for strategic decision-making and operational execution.
- Clinical Need
-
Aspect: Very Strong
Summary: The company's AI-powered medical imaging systems address critical therapeutic areas with high demand.
By focusing on prevalent and lethal diseases, the company ensures its solutions are both necessary and impactful.
- Competition
-
Aspect: Somewhat crowded
Summary: The AI medical imaging market has multiple players, though Shukun holds a strong position.
Despite competition, Shukun's comprehensive product portfolio and regulatory approvals distinguish it in the market.
- Technical Challenge
-
Aspect: Moderate
Summary: Developing AI medical imaging systems involves moderate technical complexity.
While AI development in medical imaging is complex, the company's experience mitigates these challenges.
- Patent
-
Aspect: Strong
Summary: The company has secured multiple patents for its AI medical imaging technologies.
Patents protect the company's innovations, providing a barrier to entry for competitors.
- Financing
-
Aspect: Well-funded
Summary: Shukun has raised significant funding across multiple rounds, indicating strong financial backing.
The substantial investment reflects investor confidence and provides resources for growth.
- Regulatory
-
Aspect: 510k/PMA
Summary: The company has obtained NMPA Class III certificates and MDR CE markings for its products.
Achieving these certifications demonstrates compliance with stringent standards, enhancing credibility.
Opportunity Rollup
- Odds of Success
- 4
- Peak Market Share
- 5.7
- Segment CAGR
- 9.1%
- Market Segment
- AI Medical Imaging
- Market Sub Segment
- Cardiovascular and Pulmonary Diagnostics
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.29 |
| 2 | 0.86 |
| 3 | 2.00 |
| 4 | 3.99 |
| 5 | 5.70 |
Key Takeaway
Shukun Technology's strong team, comprehensive product portfolio, and robust funding position it well in the growing AI medical imaging market, despite competitive and regulatory challenges.